Tag Archives: LGND

Best Financial Stocks To Watch For 2019

Investors in NVIDIA (NASDAQ:NVDA) have had a lot to celebrate. The company’s graphics processing unit (GPU) remains the gold standard among hardcore and casual gamers alike, and the advent of cloud computing and artificial intelligence (AI) have created vast new markets for NVIDIA’s products.

These developments have led to massive growth, with revenue from the last fiscal year nearly doubling compared to just two years ago. The stock price has followed the financial results, up more than 81% — four times the return of the S&P 500. The company will need to produce blockbuster earnings to keep that trend going.

NVIDIA is scheduled to reports its financial results for its first quarter on Thursday, May 10, after the market closes. Here are some of the things investors should look for.

What will the quarter hold for NVIDIA investors? Image source: NVIDIA.

Best Financial Stocks To Watch For 2019: AmeriGas Partners, L.P.(APU)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Amerigas Partners LP  (NYSE:APU)Q1 2019 Earnings Conference CallFeb. 06, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By John Bromels]

    If you’re like me, you probably use branded propane tanks from AmeriGas Partners (NYSE:APU) or Blue Rhino, which is owned by Ferrellgas Partners, L.P. (NYSE:FGP) (Full disclosure: Propane is propane. I use AmeriGas because it’s what the local convenience store sells.) Either one will get your burgers cooked, but which one will keep your portfolio cooking along? 

  • [By John Bromels]

    I use propane tanks from AmeriGas Partners (NYSE:APU) because that’s what my local convenience store sells, but many outdoor cooks use Blue Rhino, which is owned by Ferrellgas Partners, L.P. (NYSE:FGP). There’s no difference between them when it comes to getting your burgers browned or your ribs crispy — propane is propane, after all, regardless of who’s selling it — but there are big differences in the two companies from an investor’s standpoint. 

  • [By Maxx Chatsko]

    Investors seeking income from energy stocks will find it difficult to match the impressive yields of Ferrellgas Partners LP (NYSE:FGP) and AmeriGas Partners (NYSE:APU), which sit at 11.9% and 9%, respectively. However, this is a textbook case of higher yields representing higher levels of risk.

Best Financial Stocks To Watch For 2019: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Cory Renauer]

    Finding a partner for VK5211 or VK2809 will be a bit more challenging than usual because Viking doesn’t own the drugs outright. Viking licensed them from Ligand Pharmaceuticals (NASDAQ:LGND) a few years ago and owes Ligand single-digit royalties on any sales either drug might generate. Coincidentally, Madrigal entered a similar agreement with Roche to get its hands on MGL-3196 back in 2008.

  • [By Keith Speights]

    Which companies that are relatively small right now could become the big biotechs of the future? Here’s why I think that Editas Medicine (NASDAQ:EDIT), Ligand Pharmaceuticals (NASDAQ:LGND), and Exelixis (NASDAQ:EXEL) could be monster biotech stocks in the making.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    These are some of the news stories that may have effected Accern Sentiment’s scoring:

    Get Ligand Pharmaceuticals alerts:

    Ligand Pharmaceuticals (LGND) Insider Sells $1,488,722.03 in Stock (americanbankingnews.com) Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down (finance.yahoo.com) Ligand Pharmaceuticals (LGND) Upgraded to A- by TheStreet (americanbankingnews.com) Ligand to Participate in Upcoming Investor Conferences (finance.yahoo.com) Ligand Pharmaceuticals Shows Rising Price Performance With Jump To 87 RS Rating (investors.com)

    A number of research firms recently issued reports on LGND. TheStreet raised Ligand Pharmaceuticals from a “c+” rating to an “a-” rating in a research report on Wednesday. HC Wainwright reissued a “buy” rating and set a $170.00 price objective on shares of Ligand Pharmaceuticals in a research report on Friday, February 2nd. Zacks Investment Research raised Ligand Pharmaceuticals from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, February 28th. BidaskClub cut Ligand Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Roth Capital lifted their price objective on Ligand Pharmaceuticals from $158.00 to $171.00 and gave the company a “buy” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $161.00.

  • [By Reuben Gregg Brewer, Keith Speights, and Brian Stoffel]

    That’s certainly the case with surprisingly diversified biotech company Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), out-of-favor outlet mall owner Tanger Factory Outlet Centers, Inc. (NYSE:SKT), and expanding software-maker New Relic, Inc. (NYSE:NEWR). Take the time for a deep dive, and you might find that one of these three mid-cap stocks is just right for your portfolio today.

  • [By Jon C. Ogg]

    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) was maintained as Buy at Argus, but the firm lowered its target to $150 from $200. The independent research firm noted that recent weakness offers a buying opportunity as the company is believed to be on track to post solid earnings growth over the next several years. Ligand closed up 1.5% at $119.76 on Tuesday, in a 52-week range of $98.56 to $278.62.

Best Financial Stocks To Watch For 2019: Statoil ASA(STO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Statoil (NYSE: STO) and Delek US (NYSE:DK) are both oils/energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, dividends, profitability and risk.

  • [By Tyler Crowe]

    Anyone that has watched oil prices tick up recently has probably expected oil producers to report some impressive earnings results this past quarter, and Statoil (NYSE:STO) did just that with a 21% boost to the bottom line. At the same time, management is using all of its additional cash to do some wheeling and dealing that should help boost its growth possibilities in the nearer term.

  • [By Matthew DiLallo]

    Another highlight in April was that Shell gave the green light to the Vito project, which is a joint venture with Statoil (NYSE:STO) in the Gulf of Mexico. Shell and Statoil were able to cut that project’s cost estimate by 70% from the original design so that it’s now profitable at $35 a barrel. The partners expect the project to produce 100,000 BOE/D of low-cost oil and gas when it comes online in 2021.

Hot Performing Stocks To Own For 2019

L Brands (LB) soared to the top of the S&P 500 today after the parent company of Victoria’s Secret reported a 10% drop in same-store sales.

Agence France-Presse/Getty Images

L Brands surged 11% to $47.85 today, while the S&P 500 rose 0.2% to 2,357.49. And while L Brands was the best performer, retailers made up half of the 10 best performing stocks in the benchmark today: Nordstrom (JWN) advanced 2.9% to $44.71, Gap (GPS) jumped 5.1% to $24.06, Kohl’s (KSS) climbed 5.6% to $39.60, and Bed Bath & Beyond (BBBY), which reported earnings last night, gained 3.4% to $39.08.

RBC analysts Brian Tunick and Kate Fitzsimons attributed L Brand’s big move to a short squeeze. They explain:

Bottom line, with the stock recently hitting a 52 week low yesterday, the 10% squeeze we’re seeing in the shares is likely reflective of the “better-than-feared” trade rather than long-only buyers stepping in. The reality is that LB’s fundamentals are still challenged (down 10% comps are nothing to throw a party for), with the overhang on LB shares related to how much of the damage is self-inflicted (7% category exit headwind called out this month) vs. a tough mall traffic environment. Net/net, we remain neutral on LB shares given the lack of top line visibility as LB executes these category exits, with April and 2Q17’s merch margin commentary ones to watch for signals that we’ve rounded the bottom.

Hot Performing Stocks To Own For 2019: ING Group, N.V.(ISP)

Advisors’ Opinion:

  • [By Max Byerly]

    Intesa Sanpaolo (BIT:ISP) received a €3.00 ($3.53) price target from stock analysts at HSBC in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the stock. HSBC’s target price points to a potential downside of 2.60% from the stock’s current price.

  • [By Stephan Byrd]

    Goldman Sachs Group set a €2.90 ($3.37) price target on Intesa Sanpaolo (BIT:ISP) in a report published on Wednesday. The firm currently has a neutral rating on the stock.

Hot Performing Stocks To Own For 2019: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights, Chuck Saletta, and Brian Feroldi]

    That’s the question we presented to three Motley Fool contributors. They identified Ligand Pharmaceuticals (NASDAQ:LGND), Portola Pharmaceuticals (NASDAQ:PTLA), and Supernus Pharmaceuticals (NASDAQ:SUPN) as top biotech stocks to buy in September. Here’s why these biotechs stood out:

  • [By Keith Speights]

    Which companies that are relatively small right now could become the big biotechs of the future? Here’s why I think that Editas Medicine (NASDAQ:EDIT), Ligand Pharmaceuticals (NASDAQ:LGND), and Exelixis (NASDAQ:EXEL) could be monster biotech stocks in the making.

  • [By Shane Hupp]

    Ligand Pharmaceuticals Inc. (NASDAQ:LGND) Director Todd C. Davis sold 9,000 shares of Ligand Pharmaceuticals stock in a transaction on Friday, August 17th. The shares were sold at an average price of $239.78, for a total transaction of $2,158,020.00. Following the transaction, the director now owns 44,806 shares in the company, valued at approximately $10,743,582.68. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Performing Stocks To Own For 2019: MoSys, Inc.(MOSY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MoSys (MOSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    MoSys, Inc. (NASDAQ: MOSY) shares were also up, gaining 27 percent to $1.9265 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 10 Performing Stocks To Own For 2019

Source: ThinkstockApril 4, 2018: The S&P 500 closed up 1.2% at 2,644.67. The DJIA closed up 1.0% at 24,263.54. Separately, the Nasdaq was up 1.5% at 7,042.11.

Wednesday ended up being a positive day for the broad U.S. markets. The major indices started the day out incredibly negative and over the course of the day worked their way up to a strong close. The S&P 500 saw a swing of roughly 75 points on the day, while the Dow had a swing of nearly 800 points. Again, the biggest gain in the session came towards the end of the session. The S&P 500 sectors were entirely positive. The most positive sectors were consumer discretionary, consumer staples, and health care up 2.0%, 1.8%, and 1.7%, respectively. The worst performing sector was energy which was up less than 0.1%.

Top 10 Performing Stocks To Own For 2019: Enable Midstream Partners, LP(ENBL)

Advisors’ Opinion:

  • [By Lee Jackson]

    Enable Midstream Partners LP (NYSE: ENBL) is raised to equal weight from underweight at Barclays. The 52-week trading range for the stock has been $12.89 to $17.67. The consensus price target is set at $17.18. The price of shares at the market’s close on Monday was $17.02.

  • [By Stephan Byrd]

    Enable Midstream Partners (NYSE: ENBL) and EnLink Midstream Partners (NYSE:ENLK) are both mid-cap oils/energy companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Enable Midstream Partners (ENBL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Enable Midstream Partners LP (NYSE:ENBL) has been given a consensus recommendation of “Hold” by the fourteen ratings firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $17.75.

Top 10 Performing Stocks To Own For 2019: WSB Holdings Inc.(WSB)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Markets have been under pressure once again by the U.S. Federal Reserve. Inflation levels are going through the roof… but the people in charge of managing it have been lying to Americans for years. Now it’s time to get even.Money MorningLiquidity Specialist Lee Adler has the perfect way to make a lot of money when no one is looking.Read it here.

    The Top Stock Market Stories for Wednesday
    In addition to Trump’s concerns about China and trade, the President also stated that he is unsure whether a summit with North Korean leader Kim Jong-Un will take place as planned. Multiple media outlets this morning are questioning if the event will take place. The summit is tentatively planned for June 12. Banking stocks were on the move after Congress passed new laws designed to reduce regulations for thousands of financial institutions. The new rules will ensure that smaller banks are not facing the same strict rules as the bigger giants. The financial sector has been lobbying to changes to the Dodd-Frank Act since its inception after the 2008-09 financial crisis. Facebook Inc. (Nasdaq: FB) CEO Mark Zuckerberg met with members of the European Union on Tuesday. The CEO of the social media giant outraged European Parliament members after reportedly dodging questions about user privacy and the firm’s collection of personal data. During the conversation, EU members questioned whether Facebook is a monopoly and pondered if the firm should be broken up due to antitrust concerns.
    Three Stocks to Watch Today: TGT, LOW, TIF
    Shares of Target Corporation (NYSE: TGT) fell nearly 6% after the retail giant fell short of earnings expectations before the bell. The firm reported earnings per share of $1.32. This figure missed Wall Street earnings expectations by six cents. The retail giant blamed poor spring weather for its performance and said that its bottom line has been impacted by the costs of upgrading its physical locations. Lowe’s Companies (NYSE: LOW) stock gained

Top 10 Performing Stocks To Own For 2019: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Vanda Pharmaceuticals (VNDA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Media stories about Vanda Pharmaceuticals (NASDAQ:VNDA) have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vanda Pharmaceuticals earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave media coverage about the biopharmaceutical company an impact score of 46.3857713397213 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Stephan Byrd]

    Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $22.40.

Top 10 Performing Stocks To Own For 2019: FormFactor, Inc.(FORM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on FormFactor (FORM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

Top 10 Performing Stocks To Own For 2019: New Oriental Education & Technology Group, Inc.(EDU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    EduCoin (EDU) is a PoW/PoS token that uses the Keccak hashing algorithm. It launched on September 9th, 2017. EduCoin’s total supply is 15,000,000,000 tokens. EduCoin’s official website is www.edu.one. EduCoin’s official Twitter account is @PReducoin.

  • [By Ethan Ryder]

    Strayer Education (NASDAQ: STRA) and New Oriental Education & Tech Grp (NYSE:EDU) are both consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.

  • [By Lisa Levin] Gainers
    SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
    EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
    Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
    Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose
  • [By Ethan Ryder]

    New Oriental (NYSE: EDU) and The Graham (NYSE:GHC) are both consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations.

  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D

Top 10 Performing Stocks To Own For 2019: Frontline Ltd.(FRO)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Shane Hupp]

    Diana Shipping (NYSE: DSX) and Frontline (NYSE:FRO) are both small-cap transportation companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

  • [By Asit Sharma]

    Last year, net income dropped from $146.4 million to $101.2 million, creating the sharp trend line seen above. The 2017 earnings dip can be traced to numerous factors, including higher interest expense, a reduction in tanker income, fewer ships in the fleet on charter to former parent Frontline Shipping (NYSE:FRO), and the bankruptcy filing of Seadrill Ltd. (NYSE:SDRL). Seadrill’s reorganization has impacted Ship Finance’s offshore revenue, as it has three out of four offshore drilling rigs on charter to affiliates of Seadrill.

  • [By ]

    What Happened
    Shares of Frontline Ltd. (NYSE:FRO) surged more than 13% by 10:00 a.m. EDT on Thursday after the oil tanker company posted better-than-expected first-quarter results.

  • [By Matthew DiLallo]

    Shares of Frontline Ltd.(NYSE:FRO) surged more than 13% by 10:00 a.m. EDT on Thursday after the oil tanker company posted better-than-expected first-quarter results.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Frontline (FRO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Own For 2019: Cogentix Medical, Inc.(CGNT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News coverage about Vision Sciences (NASDAQ:CGNT) has trended somewhat positive on Friday, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Vision Sciences earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave news headlines about the medical device company an impact score of 43.7920504117832 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Performing Stocks To Own For 2019: General Employment Enterprises, Inc.(JOB)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Valeritas Holdings, Inc. (NASDAQ: VLRX) shares jumped 17 percent to $3.65.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares rose 13.5 percent to $11.70.
    McDermott International, Inc. (NYSE: MDR) gained 11.6 percent to $6.75 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Nautilus, Inc. (NYSE: NLS) shares jumped 11.2 percent to $14.95. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    GEE Group, Inc. (NYSE: JOB) shares gained 11 percent to $2.2199.
    Check-Cap Ltd. (NASDAQ: CHEK) surged 10.8 percent to $4.50.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) rose 10.1 percent to $3.39.
    Stars Group Inc. (NASDAQ: TSG) climbed 9.6 percent to $32.10. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    Insmed Incorporated (NASDAQ: INSM) shares jumped 9.1 percent to $25.66. Credit Suisse upgraded Insmed from Neutral to Outperform.
    Tennant Company (NYSE: TNC) rose 8.4 percent to $75.65 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Command Security Corporation (NYSE: MOC) shares gained 6.4 percent to $3.0960 after the company disclosed a $23 million five-year contract with LaGuardia Gateway Partners for LaGuardia Airport New Central Terminal Building.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 6.2 percent to $2.41 after falling 10.98 percent on Friday.
    Vectren Corporation (NYSE: VVC) shares rose 5.7 percent to $69.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Hanesbrands Inc. (NYSE: HBI) gained 4.9 percent to $18.035. Stifel Nicolaus upgraded Hanesbrands from Hold to Buy.
    M
  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 78.82 percent to close at $7.26 on Monday.
    GEE Group, Inc. (NYSE: JOB) shares jumped 18 percent to close at $2.36.
    McDermott International, Inc. (NYSE: MDR) climbed 15.7 percent to close at $7.00 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) gained 17.21 percent to close at $3.61.
    Stars Group Inc. (NASDAQ: TSG) rose 14.16 percent to close at $33.45. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares jumped 12.79 percent to close at $25.58.
    Nautilus, Inc. (NYSE: NLS) shares gained 11.52 percent to close at $15.00. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    Box, Inc. (NYSE: BOX) rose 10.94 percent to close at $22.91.
    Insmed Incorporated (NASDAQ: INSM) shares rose 10.76 percent to close at $26.05. Credit Suisse upgraded Insmed from Neutral to Outperform.
    NextDecade Corporation (NASDAQ: NEXT) shares rose 10.02 percent to close at $6.48.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) shares gained 8.37 percent to close at $2.46 on Monday after falling 10.98 percent on Friday.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares gained 7.81 percent to close at $11.11.
    Vectren Corporation (NYSE: VVC) shares rose 7.26 percent to close at $70.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Tennant Company (NYSE: TNC) rose 6.66 percent to close at $74.45 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Hanesbrands Inc.
  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 10 Performing Stocks To Own For 2019: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Stephan Byrd]

    New York State Common Retirement Fund raised its stake in shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) by 30.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 56,216 shares of the biotechnology company’s stock after purchasing an additional 13,219 shares during the period. New York State Common Retirement Fund owned 0.27% of Ligand Pharmaceuticals worth $9,285,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    These are some of the news stories that may have effected Accern Sentiment’s scoring:

    Get Ligand Pharmaceuticals alerts:

    Ligand Pharmaceuticals (LGND) Insider Sells $1,488,722.03 in Stock (americanbankingnews.com) Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down (finance.yahoo.com) Ligand Pharmaceuticals (LGND) Upgraded to A- by TheStreet (americanbankingnews.com) Ligand to Participate in Upcoming Investor Conferences (finance.yahoo.com) Ligand Pharmaceuticals Shows Rising Price Performance With Jump To 87 RS Rating (investors.com)

    A number of research firms recently issued reports on LGND. TheStreet raised Ligand Pharmaceuticals from a “c+” rating to an “a-” rating in a research report on Wednesday. HC Wainwright reissued a “buy” rating and set a $170.00 price objective on shares of Ligand Pharmaceuticals in a research report on Friday, February 2nd. Zacks Investment Research raised Ligand Pharmaceuticals from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, February 28th. BidaskClub cut Ligand Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Roth Capital lifted their price objective on Ligand Pharmaceuticals from $158.00 to $171.00 and gave the company a “buy” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $161.00.

  • [By Logan Wallace]

    Ligand Pharmaceuticals (NASDAQ:LGND) announced its quarterly earnings results on Tuesday. The biotechnology company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.98, Bloomberg Earnings reports. The firm had revenue of $56.16 million during the quarter, compared to analysts’ expectations of $43.02 million. Ligand Pharmaceuticals had a net margin of 8.90% and a return on equity of 14.44%. The company’s revenue for the quarter was up 91.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.57 earnings per share. Ligand Pharmaceuticals updated its FY18 guidance to $4.85 EPS.

Top 10 Performing Stocks To Own For 2019: Materialise NV(MTLS)

Advisors’ Opinion:

  • [By Logan Wallace]

    News coverage about Materialise (NASDAQ:MTLS) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Materialise earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned news headlines about the software maker an impact score of 46.5867221134452 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top Heal Care Stocks To Own For 2018

Like any single currency area, the eurozone has only one AD. Thats true despite the fact that it contains 19 countries. In contrast, China has 4 ADs, for Mainland China, Hong Kong, Macao and Taiwan. (The Taiwanese constitution says they are part of China, who am I to argue?)

Here is the eurozone unemployment rate:

The disastrous policy tightening of 2011 pushed eurozone unemployment up from 10% to 12%. Then policy eased slightly, and NGDP started growing again. Unemployment fell back to 10%, about the rate of 1999, when the euro was created.

Top Heal Care Stocks To Own For 2018: New Mountain Finance Corporation(NMFC)

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the news headlines that may have effected Accern Sentiment’s scoring:

    Get New Mountain Finance alerts:

    New Mountain Finance (NMFC) Expected to Post Quarterly Sales of $50.86 Million (americanbankingnews.com) Zacks: Analysts Anticipate New Mountain Finance (NMFC) Will Post Earnings of $0.34 Per Share (americanbankingnews.com) New Mountain Finance (NMFC) Stock Rating Lowered by Zacks Investment Research (americanbankingnews.com) Is this stock is more Volatile? New Mountain Finance Corporation (NMFC) (stockquote.review) New Mountain Finance Corporation (NMFC): Stock Have a Latest Story: (mosttradedstocks.com)

    A number of equities analysts have recently weighed in on NMFC shares. Zacks Investment Research raised shares of New Mountain Finance from a “hold” rating to a “buy” rating and set a $15.00 price target on the stock in a research note on Wednesday, March 21st. TheStreet downgraded shares of New Mountain Finance from a “b” rating to a “c+” rating in a research note on Wednesday, April 11th. ValuEngine downgraded shares of New Mountain Finance from a “buy” rating to a “hold” rating in a research note on Monday, April 2nd. Finally, Keefe, Bruyette & Woods set a $15.00 price target on shares of New Mountain Finance and gave the stock a “hold” rating in a research note on Thursday, March 1st. One investment analyst has rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $15.00.

Top Heal Care Stocks To Own For 2018: Bank of Hawaii Corporation(BOH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Hasbro, Inc. (NASDAQ: HAS) reported weaker-than-expected results for its first quarter on Monday.
    Subsea 7 S.A. confirmed a $7.00 per share proposal to acquire McDermott International Inc (NYSE: MDR).
    CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren Corp (NYSE: VVC) for $72 per share in cash.
    Bank of Hawaii Corporation (NYSE: BOH) reported upbeat earnings for its first quarter.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Kimberly-Clark Corporation (NYSE: KMB) is expected to report quarterly earnings at $1.71 per share on revenue of $4.60 billion.
    Halliburton Company (NYSE: HAL) is projected to report quarterly earnings at $0.42 per share on revenue of $5.75 billion.
    Lennox International Inc. (NYSE: LII) is estimated to report quarterly earnings at $1.09 per share on revenue of $815.16 million.
    Alaska Air Group, Inc. (NYSE: ALK) is projected to report quarterly loss at $0.12 per share on revenue of $1.82 billion.
    Hasbro, Inc. (NASDAQ: HAS) is expected to report quarterly earnings at $0.35 per share on revenue of $822.15 million.
    Lincoln Electric Holdings, Inc. (NASDAQ: LECO) is projected to report quarterly earnings at $1.08 per share on revenue of $729.83 million.
    Tennant Company (NYSE: TNC) is estimated to report quarterly earnings at $0.15 per share on revenue of $251.93 million.
    FirstEnergy Corp. (NYSE: FE) is projected to report quarterly earnings at $0.67 per share on revenue of $3.43 billion.
    Koninklijke Philips NV (ADR) (NYSE: PHG) is estimated to report earnings for its first quarter.
    Bank of Hawaii Corporation (NYSE: BOH) is expected to report quarterly earnings at $1.23 per share on revenue of $162.39 million.
    Avangrid, Inc. (NYSE: AGR) is projected to report quarterly earnings at $0.79 per share on revenue of $1.72 billion.

     

Top Heal Care Stocks To Own For 2018: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the news stories that may have effected Accern Sentiment’s scoring:

    Get Ligand Pharmaceuticals alerts:

    Ligand Pharmaceuticals (LGND) Insider Sells $1,488,722.03 in Stock (americanbankingnews.com) Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down (finance.yahoo.com) Ligand Pharmaceuticals (LGND) Upgraded to A- by TheStreet (americanbankingnews.com) Ligand to Participate in Upcoming Investor Conferences (finance.yahoo.com) Ligand Pharmaceuticals Shows Rising Price Performance With Jump To 87 RS Rating (investors.com)

    A number of research firms recently issued reports on LGND. TheStreet raised Ligand Pharmaceuticals from a “c+” rating to an “a-” rating in a research report on Wednesday. HC Wainwright reissued a “buy” rating and set a $170.00 price objective on shares of Ligand Pharmaceuticals in a research report on Friday, February 2nd. Zacks Investment Research raised Ligand Pharmaceuticals from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, February 28th. BidaskClub cut Ligand Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Roth Capital lifted their price objective on Ligand Pharmaceuticals from $158.00 to $171.00 and gave the company a “buy” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $161.00.

  • [By Logan Wallace]

    Ligand Pharmaceuticals (NASDAQ:LGND) announced its quarterly earnings results on Tuesday. The biotechnology company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.98, Bloomberg Earnings reports. The firm had revenue of $56.16 million during the quarter, compared to analysts’ expectations of $43.02 million. Ligand Pharmaceuticals had a net margin of 8.90% and a return on equity of 14.44%. The company’s revenue for the quarter was up 91.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.57 earnings per share. Ligand Pharmaceuticals updated its FY18 guidance to $4.85 EPS.

Top Heal Care Stocks To Own For 2018: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Ethan Ryder]

    Teladoc (NYSE: TDOC) and Envision Healthcare (NYSE:EVHC) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability.

  • [By Max Byerly]

    Envision Healthcare (NYSE:EVHC) issued an update on its second quarter earnings guidance on Monday morning. The company provided earnings per share guidance of $0.83-0.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.91. Envision Healthcare also updated its FY18 guidance to $3.49-3.70 EPS.

Top 5 Stocks To Watch Right Now

AdvanSix (NYSE:ASIX) Director Michael Marberry bought 1,398 shares of the stock in a transaction on Monday, May 7th. The stock was purchased at an average price of $35.74 per share, for a total transaction of $49,964.52. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Michael Marberry also recently made the following trade(s):

Get AdvanSix alerts:

On Thursday, April 12th, Michael Marberry bought 714 shares of AdvanSix stock. The stock was purchased at an average price of $34.95 per share, for a total transaction of $24,954.30. On Friday, April 6th, Michael Marberry bought 685 shares of AdvanSix stock. The stock was purchased at an average price of $36.50 per share, for a total transaction of $25,002.50. On Friday, March 23rd, Michael Marberry bought 715 shares of AdvanSix stock. The stock was purchased at an average price of $34.97 per share, for a total transaction of $25,003.55. On Thursday, March 8th, Michael Marberry bought 574 shares of AdvanSix stock. The stock was purchased at an average price of $43.51 per share, for a total transaction of $24,974.74.

Shares of ASIX traded up $0.82 during trading hours on Tuesday, hitting $35.12. 286,561 shares of the company were exchanged, compared to its average volume of 306,404. The company has a market cap of $1.11 billion, a PE ratio of 11.71 and a beta of 1.44. AdvanSix has a 52 week low of $26.54 and a 52 week high of $46.51. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.72 and a current ratio of 1.17.

Top 5 Stocks To Watch Right Now: Euro Tech Holdings Company Limited(CLWT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 34.7 percent to $45.50 in pre-market trading following news that the FDA has approved Andexxa for the reversal of factor Xa inhibitors.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 15.7 percent to $6.65 in pre-market trading after climbing 155.56 percent on Thursday.
    China Recycling Energy Corporation (NASDAQ: CREG) rose 14.7 percent to $2.75 in pre-market trading after climbing 57.89 percent on Thursday.
    Pandora Media, Inc. (NYSE: P) rose 11 percent to $6.40 in pre-market trading after reporting strong quarterly results.
    Fred's, Inc. (NASDAQ: FRED) rose 9.2 percent to $1.90 in pre-market trading following Q4 results.
    Shake Shack Inc (NYSE: SHAK) rose 9.1 percent to $51.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) rose 9 percent to $12.55 in pre-market trading after the company posted Q1 results and agreed to acquire HealthGrid.
    Weight Watchers International, Inc. (NYSE: WTW) rose 7.6 percent to $75 in pre-market trading after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings outlook from $2.40-$2.70 to $3-$3.20.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7.5 percent to $10.15 in pre-market trading following Q3 results.
    Pearson plc (NYSE: PSO) rose 4.5 percent to $11.83 in pre-market trading after reporting strong quarterly earnings.
    Alibaba Group Holding Ltd (NYSE: BABA) shares rose 4.4 percent to $190.50 in the pre-market trading session as the company posted upbeat Q4 results.
    Aqua Metals, Inc. (NASDAQ: AQMS) shares rose 3.9 percent to $4.30 in pre-market trading after gaining 6.98 percent on Thursday.
    Newell Brands Inc (NYSE: NWL) shares rose 3.6 percent to $27.65 in pre-market trading after reporting upbeat quarterly earnings.
    HMS Holdings Corp (NASDAQ: H
  • [By Money Morning News Team]

    However, VivoPower and our other penny stocks to watch this week already saw big gains. After looking at our 10 top penny stocks to watch, we’ll show you a small-cap stock with serious profit potential in its future…

    Penny Stock Current Share Price Law Week’s Gain
    VivoPower International Plc. (Nasdaq: VVPR) $3.05 88.57%
    Euro Tech Holdings Co. (Nasdaq: CLWT) $3.77 75.11%
    Boxlight Corp. (Nasdaq: BOXL) $6.36 65.38%
    Chine Recycling Energy Corp. (Nasdaq: CREG) $2.01 45.92%
    Vivis Inc. (Nasdaq: VVUS) $0.52 38.82%
    HC2 Holdings Inc. (NYSE: HCHC) $6.79 33.49%
    Biostar Pharmaceuticals Inc. (Nasdaq: BSPM) $2.67 32.23%
    Turtle Beach Corp. (Nasdaq: HEAR) $6.99 30.19%
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $3.30 29.24%
    Rexahn Pharmaceuticals Inc. (NYSE: RNN) $2.11 29.19%

    While the gains of last week’s top penny stocks are exciting, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)

Top 5 Stocks To Watch Right Now: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Logan Wallace]

    Ligand Pharmaceuticals (NASDAQ:LGND) announced its quarterly earnings results on Tuesday. The biotechnology company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.98, Bloomberg Earnings reports. The firm had revenue of $56.16 million during the quarter, compared to analysts’ expectations of $43.02 million. Ligand Pharmaceuticals had a net margin of 8.90% and a return on equity of 14.44%. The company’s revenue for the quarter was up 91.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.57 earnings per share. Ligand Pharmaceuticals updated its FY18 guidance to $4.85 EPS.

  • [By Logan Wallace]

    These are some of the news stories that may have effected Accern Sentiment’s scoring:

    Get Ligand Pharmaceuticals alerts:

    Ligand Pharmaceuticals (LGND) Insider Sells $1,488,722.03 in Stock (americanbankingnews.com) Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down (finance.yahoo.com) Ligand Pharmaceuticals (LGND) Upgraded to A- by TheStreet (americanbankingnews.com) Ligand to Participate in Upcoming Investor Conferences (finance.yahoo.com) Ligand Pharmaceuticals Shows Rising Price Performance With Jump To 87 RS Rating (investors.com)

    A number of research firms recently issued reports on LGND. TheStreet raised Ligand Pharmaceuticals from a “c+” rating to an “a-” rating in a research report on Wednesday. HC Wainwright reissued a “buy” rating and set a $170.00 price objective on shares of Ligand Pharmaceuticals in a research report on Friday, February 2nd. Zacks Investment Research raised Ligand Pharmaceuticals from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, February 28th. BidaskClub cut Ligand Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Roth Capital lifted their price objective on Ligand Pharmaceuticals from $158.00 to $171.00 and gave the company a “buy” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $161.00.

Top 5 Stocks To Watch Right Now: CA Inc.(CA)

Advisors’ Opinion:

  • [By Shane Hupp]

    CA Technologies (NASDAQ:CA) issued an update on its FY19 earnings guidance on Tuesday morning. The company provided EPS guidance of $2.75-$2.81 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.74. The company issued revenue guidance of $4.25-$4.29 billion, compared to the consensus revenue estimate of $4.31 billion.

  • [By Joseph Griffin]

    CA Technologies (NASDAQ:CA) – Equities researchers at Oppenheimer issued their Q1 2019 earnings estimates for CA Technologies in a research note issued to investors on Wednesday, May 9th. Oppenheimer analyst S. Eyal expects that the technology company will earn $0.62 per share for the quarter. Oppenheimer currently has a “Hold” rating on the stock. Oppenheimer also issued estimates for CA Technologies’ Q2 2019 earnings at $0.66 EPS, Q3 2019 earnings at $0.68 EPS, Q4 2019 earnings at $0.62 EPS and FY2020 earnings at $2.68 EPS.

  • [By ]

    CA, Inc. (Nasdaq: CA)
    Known in a former life as Computer Associates, CA is the biggest software company you’ve never heard of. With a market cap of $13.8 billion and annual revenues in excess of $4 billion, CA provides enterprise software solutions focusing on mainframe platforms, enterprise environments, database security operations, and cloud applications.

Top 5 Stocks To Watch Right Now: Unilever N.V. (UNLVF)

Advisors’ Opinion:

  • [By ]

    In recent weeks, Procter & Gamble (PG) has received a couple of downgrades following its Q3 FY2018 results announcement. In contrast, its peer in the consumer products space, Unilever (UL)(UN)(OTCPK:UNLNF)(OTCPK:UNLYF)(OTCPK:UNLVF), was upgraded by UBS in late March. Investors also cheered the announcement of a fresh 6 billion ($7.4 billion) stock buyback program and the raising of its quarterly dividend by 8% to 0.3872/share from 0.3585. In 2017, Unilever has already completed a 5 billion share buyback programme.

Top 5 Stocks To Watch Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Fernwood Investment Management LLC lessened its holdings in shares of Blueprint Medicines (NASDAQ:BPMC) by 29.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,696 shares of the biotechnology company’s stock after selling 1,120 shares during the period. Fernwood Investment Management LLC’s holdings in Blueprint Medicines were worth $247,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile